If you have been diagnosed with leukemia or looking for a second opinion, you and your family may be facing a lot of difficult questions. The dedicated team of specialists in our Gehr Family Center for Leukemia Research can answer your questions, address your concerns, and design a personalized treatment plan with the most innovative therapies available anywhere.

We bring together a broad array of leukemia expertise from multiple disciplines with an unmatched reputation for coordinated, compassionate care:

  • State-of-the-art screenings and diagnostic tools
  • Pioneering drug research and clinical trials
  • Unique chemotherapy, immunotherapy, radiation and stem cell transplant options
  • Exceptional family and survivorship programs; your care continues long after treatment is complete.

Request an appointment online or contact us at 800-826-HOPE. Please visit Making Your First Appointment for more information.

World-renowned Leukemia Treatment Center

  • Recognized internationally for research and breakthrough treatments of leukemia.
  • One of the largest transplant centers in the country, producing some of the consistently best outcomes.
  • Designated a Comprehensive Cancer Center by the National Cancer Institute.
  • Named by U.S. News & World Report as one of America's top cancer hospitals.

Learn More About Leukemia

Care Team

City of Hope’s renowned physicians and researchers in the Hematologic Malignancies and Stem Cell Transplantation Institute utilize the latest in technology and innovation to treat leukemia, coupled with our enduring belief in providing unparalleled compassionate care. Request an appointment online or contact us at 800-826-HOPE.

Joseph Alvarnas, M.D.

Clinical Specialties:

  • Hematology/Oncology
Stephen J. Forman, M.D., F.A.C.P.

Clinical Specialties:

  • Hematology/Oncology
Karl K Gaal, M.D.

Clinical Specialties:

  • Anatomic and Clinical Pathology
  • Hematopathology
Guido Marcucci, M.D.

Clinical Specialties:

  • Hematology/Oncology
Matthew Genyeh Mei, M.D.

Clinical Specialties:

  • Hematology/Oncology
Ryotaro Nakamura
Ryotaro Nakamura, M.D.

Clinical Specialties:

  • Hematologic Malignancies
  • Lymphoma
  • Leukemia
  • Myelodysplastic Syndrome
  • Aplastic Anemia
Margaret O Donnell headshot photo
Margaret R O'Donnell, M.D., F.R.C.P.C.

Clinical Specialties:

  • Hematology/Oncology
Pablo M Parker, M.D.

Clinical Specialties:

  • Hematology/Oncology
Anna Pawlowska, M.D.

Clinical Specialties:

  • Pediatric Hematology/Oncology
Vinod A Pullarkat, M.D.

Clinical Specialties:

  • Hematology/Oncology
Joseph Rosenthal, M.D., M.H.C.M.

Clinical Specialties:

  • Pediatric Hematology/Oncology
Eileen P. Smith, M.D.

Clinical Specialties:

  • Hematology/Oncology
David S. Snyder, M.D., F.A.C.P.

Clinical Specialties:

  • Hematology/Oncology
Jeffrey Y.C. Wong, M.D.

Clinical Specialties:

  • Radiation Oncology

Success Stories

Gus Perez Success Story Thumbnail
Gus, leukemia survivor

“I’m going to beat this. I’m going to come back and retrace these steps.”

Nicole Schulz Success Story Image
Nicole, leukemia survivor

After two bone marrow transplants and tremendous perseverance, Nicole is back to living the life she once knew – and making up for lost time.

Tests & Treatments

Every patient is different, with different needs. Our entire team works together to bring you precise, state-of-the-art chemo, radiation and transplant options that will deliver the best outcome for you.
We were among the first to build and develop a bone marrow transplant program which has performed more than 12,000 procedures since 1976. City of Hope has been recognized for superior survival outcomes for ten consecutive years - the only transplant center in the United States with such an achievement.
Learn more about treatment options for leukemia, including:


Clinical Trials

We offer access to a wide variety of clinical trials not always available to the general public. Some of our latest research ranges from identifying and eradicating leukemia stem cells, to activating immune system or “T” cells to fight the disease.
Learn more about clinical trials. Browse through some of our clinical trials and research projects below.

  • SWOG S1312: A Phase I Study of Inotuzumab Ozogamicin (NSC-772518) in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Patients with Relapsed/Refractory CD22-Positive Acute Leukemia (Including B-ALL, Mixed Phenotypic Leukemia, and Burkitt’s Leukemia)
  • COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
  • Phase I/II Study of the Combination of Dasatinib with Chemotherapy for High Risk Acute Myeloid Leukemia (AML) Patients
  • Non-Research, Expanded Access Protocol for the Use of Gemtuzumab Ozogamicin (Mylotarg) in Patients with Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, or Myelodysplastic Syndrome, When No Other Comparable or Satisfactory Alternative Therapy are Available
  • Phase I Study to Evaluate Cellular Immunotherapy Using Central Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Lymphodepleting Chemotherapy in Adult Patients with High-Risk CD19+ Acute Lymphoblastic Leukemia
  • COG AAML1331: A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid
  • A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia
  • A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia Harboring the 17p Deletion
  • Resources

    When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your family take each step in your leukemia journey. Learn more about the resources listed below at our Living with Cancer or Supportive Care Medicine sites.

    Additional resources from our health library:


    Support the Gehr Family Center for Leukemia Research

    We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts over 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct.

    For more information on supporting the leukemia program, please contact

    Tina Pakfar, DPPD
    Vice President, Philanthropy
    Direct: 626-218-6126
    Email: [email protected]

    Amy M. Cook, Ph.D.
    Associate Director, Philanthropy
    Direct: 626-218-6228

    Email: [email protected]

    Or, you can make a gift to support all the research at City of Hope by donating online.


    An Expert's Voice

    City of Hope experts cover prevention, screening, treatment and other cancer topics on City of Hope’s Breakthrough’s blog.

    Back To Top